Pfizer vaccine appears effective against coronavirus variant found in Britain, says study

By: |
January 20, 2021 4:09 PM

The latest study, which has not yet been peer reviewed, was conducted on 10 mutations, which are characteristic of the variant known as B117 identified in Britain.

covidBut there is no reason for us to believe that they are responsible for the upsurge of the outbreak in some districts of Maharashtra and Kerala, Paul said.

The COVID-19 vaccine developed by Pfizer and BioNTech is likely to protect against a more infectious variant of the virus, which was discovered in Britain and has spread around the world, according to results of further lab tests released on Wednesday.

The encouraging results, based on an analysis of blood of participants in trials, are based on more extensive analysis than those released by the U.S. drugmaker last week.

Last week, Pfizer said a similar laboratory study showed the vaccine was effective against one key mutation, called N501Y, found in both of the highly transmissible new variants spreading in Britain and South Africa.

The latest study, which has not yet been peer reviewed, was conducted on 10 mutations, which are characteristic of the variant known as B117 identified in Britain.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Singapore: Three virus deaths in past 5 days; 98 fresh cases surface on Thursday
2Novavax seeks OK for COVID vaccine in needy countries first
3In the times of covid: Finding purpose and strength in adversity